Daily Beast: After a manufacturing screw-up ruined 15 million doses of COVID-19 vaccine, the Biden administration has stepped in to make sure it doesn’t happen again.
— Verdant Square Network DC-MD (@VSNMaryland) April 4, 2021
The Emergent BioSolutions facility in Baltimore was contracted to make vaccines from both Johnson & Johnson and AstraZeneca—but somehow mixed up the ingredients from the two.
Emergent BioSolutions Inc. Bayview facility LOL “AstraZeneca said in a statement it will work with President Joe Biden’s administration to find an alternative site” https://t.co/44gAf9DsWB https://t.co/AJJjhiY8R2
— MissMaryPrep (@MissMaryPrep) April 4, 2021
None of it was distributed, and now the Biden administration has put Johnson & Johnson in charge of the plant and put a halt to AstraZeneca production there, The New York Times reported. The newspaper notes that the reorganization puts AstraZeneca’s vaccine—which had a rocky debut overseas—in doubt in the U.S.
White House ‘stops AstraZeneca vaccine production’ at Emergent plant.Emergent BioSolutions, a contract manufacturer, had been making both the Johnson & Johnson and the AstraZeneca vaccines but alarmingly mixed up ingredients from the two. https://t.co/SzGuS9qsO0
— Adaya77 (@Adaya77) April 4, 2021
https://t.co/8fki18pblM. Emergent Biosolutions has a history of problems going back to the 1990’s. They had an exclusive DOD vaccine contract. Had cash flow issues, got a 5 fold retroactive increase in the contract price. Over 40 deficiencies after substantial help.
— Felicia Valentina (@DemFelicia) April 4, 2021